Form D · Other Health Care

Entheon Biomedical Corp.

Belcarra, A1 · CIK 0001814903

Offering snapshot reported Jun 22, 2020 · SEC filing

Reported sold
$77.3K
Offering amount: $1.3M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 3, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 22, 2020Initial$77,279No comparison4SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-369415
The additional $1,219,817 may be received upon the exercise of transferable warrants sold inside or outside the U.S. The U.S. dollar amount is based on the Bank of Canada daily average rate of exchange reported on 6/3/2020, which was Cdn$1.3504=USD$1.00.
Each Unit consists of one common share and one half of one transferable warrant. Each warrant is exercisable for one common share at Cdn $0.60 for a period of 24 months, subject to acceleration.

Source: Form D, filed Jun 22, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christopher Gondi Director
Andrew Hegle Director
Timothy Ko Director, Executive
Kelly Pladson Executive
Brandon Schwabe Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
3694 Marine Avenue
Belcarra, A1, V3H 4R8